Tawfik O W, McGregor D H
Department of Pathology and Oncology, University of Kansas Medical Center, Kansas City.
Am J Gastroenterol. 1992 Jan;87(1):82-7.
Submucosal lipohyperplasia of the ileocecal valve (ICV) is reportedly a rarely diagnosed lesion of uncertain significance. Eight cases of ICV lipohyperplasia diagnosed in surgical specimens (seven resections, one biopsy) are reviewed: three cases were associated with right lower abdominal quadrant pain and ICV mass on barium enema or operative examination, two were associated with ICV mucosal acute inflammation and necrosis, and three were incidental in resections for cecal, appendiceal, and sigmoid neoplasia. To evaluate the frequency of ICV lipohyperplasia and any associated processes, a series of 51 autopsies was studied. Regarding lipohyperplasia in these valves, 10 (19.6%) were determined to have none, 14 (27.5%) were mild, 20 (39.2%) were moderate, and 7 (13.7%) were marked cases. Degree of lipohyperplasia correlated statistically with degree of cardiac right ventricular fatty infiltration (p = 0.0001), pancreatic fatty infiltration (p = 0.0314), and greater body weight of patient (p = 0.0009). No definite correlation was demonstrated with left ventricular, adrenal, or lymph node fatty infiltration, or with hepatic fatty change, body height, age of patient, or blood glucose. Various gastrointestinal symptoms and lesions accompanied lipohyperplasia, but no definite causal relationship was identified, except for one case of marked lipohyperplasia associated with marked mucosal necrosis and acute inflammation of ICV. In conclusion, ICV lipohyperplasia is a common finding that occasionally may be associated with clinical symptoms and other valve pathology. It correlates to some extent with right ventricular and pancreatic fatty infiltration and with greater body weight.
据报道,回盲瓣(ICV)的黏膜下脂肪增生是一种诊断罕见且意义不明的病变。本文回顾了8例在手术标本中诊断出的ICV脂肪增生病例(7例切除,1例活检):3例与钡剂灌肠或手术检查时的右下象限疼痛及ICV肿物有关,2例与ICV黏膜急性炎症和坏死有关,3例在盲肠、阑尾和乙状结肠肿瘤切除术中偶然发现。为评估ICV脂肪增生的发生率及任何相关过程,对一系列51例尸检进行了研究。关于这些瓣膜的脂肪增生情况,确定10例(19.6%)无脂肪增生,14例(27.5%)为轻度,20例(39.2%)为中度,7例(13.7%)为重度。脂肪增生程度与心脏右心室脂肪浸润程度(p = 0.0001)、胰腺脂肪浸润程度(p = 0.0314)及患者体重增加相关(p = 0.0009)。未发现与左心室、肾上腺或淋巴结脂肪浸润、肝脂肪变性、身高、患者年龄或血糖有明确相关性。脂肪增生伴有各种胃肠道症状和病变,但除1例重度脂肪增生与ICV明显黏膜坏死和急性炎症相关外,未发现明确因果关系。总之,ICV脂肪增生是一种常见表现,偶尔可能与临床症状及其他瓣膜病变相关。它在一定程度上与右心室和胰腺脂肪浸润以及体重增加相关。